These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10878322)

  • 1. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.
    Siepmann J; Kranz H; Peppas NA; Bodmeier R
    Int J Pharm; 2000 May; 201(2):151-64. PubMed ID: 10878322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
    Siepmann J; Kranz H; Bodmeier R; Peppas NA
    Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model).
    Siepmann J; Peppas NA
    Pharm Res; 2000 Oct; 17(10):1290-8. PubMed ID: 11145237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix.
    Bonferoni MC; Rossi S; Ferrari F; Bertoni M; Bolhuis GK; Caramella C
    J Control Release; 1998 Feb; 51(2-3):231-9. PubMed ID: 9685921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F; Mansourpour Z; Mortazavian E; Rafiee-Tehrani N; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2017 Dec; 121():61-72. PubMed ID: 28951063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model.
    Tang L; Wigent RJ; Schwartz JB
    Pharm Dev Technol; 1999; 4(4):481-90. PubMed ID: 10578501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.
    Takka S; Rajbhandari S; Sakr A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):75-82. PubMed ID: 11438426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
    Akbari J; Nokhodchi A; Farid D; Adrangui M; Siahi-Shadbad MR; Saeedi M
    Farmaco; 2004 Feb; 59(2):155-61. PubMed ID: 14871508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ; Ryu SG; Cui JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.
    Krögel I; Bodmeier R
    J Control Release; 1999 Aug; 61(1-2):43-50. PubMed ID: 10469901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration.
    Fu XC; Wang GP; Liang WQ; Chow MS
    J Control Release; 2004 Mar; 95(2):209-16. PubMed ID: 14980769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
    Siepmann J; Peppas NA
    Adv Drug Deliv Rev; 2001 Jun; 48(2-3):139-57. PubMed ID: 11369079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of drug release in citrate buffered HPMC matrices.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP; Wang MY; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion.
    Ross AC; MacRae RJ; Walther M; Stevens HN
    J Pharm Pharmacol; 2000 Aug; 52(8):903-9. PubMed ID: 11007060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.